Developer docs
API playgroundTry for free, no card

Search company profiles

Cellecta

Full company profile

uuid0008f5q

Namestring
Cellecta
Legal namestring
Cellecta, Inc.
Websiteurl
cellecta.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Cellecta, Inc. is a private functional genomics tools and services company founded in 2006 and headquartered in Mountain View, California. The company develops and commercializes pooled lentiviral libraries and related reagents that enable CRISPR knockout, CRISPRa activation, CRISPRi interference, and shRNA knockdown screens in mammalian cells. Its catalog spans approximately 118 products across CRISPR and RNAi libraries, Cas9/dCas9-expressing cell lines, lentiviral packaging reagents, NGS prep kits, and CloneTracker cell-barcoding libraries for single-cell Perturb-Seq workflows, alongside specialized assays including DriverMap AIR (TCR/BCR repertoire profiling) and DriverMap EXP (targeted RNA-Seq expression profiling from samples as small as 30 uL of dried blood). Differentiated technologies include proprietary HEAT/HECG tracrRNA modifications for enhanced Cas9 interaction, commercially unique dual-sgRNA CRISPRa/CRISPRi constructs, and integrated barcoding libraries for clonal tracking.

Cellecta monetizes through a hybrid of one-time catalog product sales and fee-for-service engagements. Library products price from $8,500 to $10,500; Cas9/dCas9 cell lines from $6,000 to $8,400; DriverMap AIR kits from $1,450; and cloning vectors and controls from $390 to $850. Service revenue is generated from full-service CRISPR/RNAi screening, custom library construction, cell engineering, sequencing, and bioinformatics analysis, all priced on a quote basis. Distribution is primarily direct via a Shopify-based e-commerce platform, supplemented by phone/email sales and an international distributor network. A promotional pricing mechanism ("Buy a Library, Get 30% off a Support Product," expiring September 30, 2026) signals active commercial levers.

The company serves three primary customer segments: academic and government research institutions (universities, NIH-funded labs, research hospitals), pharmaceutical and biotechnology companies (target validation, CAR-T and immunotherapy development, drug-resistance studies), and CROs offering fee-for-service genomic screening. Marketing relies on scientific content, peer-reviewed citations, technical documentation, and conference participation (CCIC, SITC, AMP in 2026). Cellecta maintains two named leaders: founder and President Alex Chenchik, and Director of R&D Donato Tedesco. The company is funded in part through NIH grants and has not disclosed any external venture capital rounds or revenue figures. A May 2025 partnership with Neoteryx extends the DriverMap EXP platform into decentralized, at-home blood microsampling workflows.

Short descriptiontext

Cellecta is a private functional genomics company that develops and sells pooled lentiviral CRISPR and shRNA libraries, Cas9/dCas9 cell lines, immune-receptor profiling assays, and bioinformatics services to academic researchers, pharmaceutical companies, and CROs for drug-target and biomarker discovery.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMountain View, United States
HQ citystring
Mountain View
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
CRISPR pooled libraries, RNAi screening services, functional genomics tools, lentiviral sgRNA libraries, immune receptor profiling
Industry3 codes
PRIMARYHLAAAIAG
CRISPR & Functional Genomics Screening Platforms (pooled/arrayed screens, perturb-seq)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Functional Genomics Research Tools and Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Research Products (Libraries & Reagents)
TypeOne Time License
Description

Sale of CRISPR sgRNA libraries, shRNA knockdown libraries, lentiviral constructs, Cas9 cell lines, cloning vectors, and related molecular biology reagents for functional genomics research.

cellecta.com
2Screening Services
TypeProfessional Services
Description

Full-service CRISPR/RNAi screening services including cell engineering, genetic screens, bioinformatics analysis, and sequencing services for customers who prefer outsourcing.

cellecta.com
3Analysis Services
TypeProfessional Services
Description

Bioinformatics data analysis services for genetic screens, AIR profiling assays, and targeted RNA-Seq including standard and custom reports.

cellecta.com
4Custom Library Construction
TypeProfessional Services
Description

Custom sgRNA and shRNA library design and production services targeting specific gene sets for research applications.

cellecta.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details9 tiers
1CRISPR Knockout Pooled Lentiviral sgRNA Libraries
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Human Genome Knockout Libraries from $8,500; Mouse Genome 86K Knockout Library from $9,500; Livestock and Poultry libraries from $9,500; Custom sgRNA libraries available (quote-based). Available in plasmid and pre-packaged lentiviral formats.

cellecta.com
2CRISPRa/CRISPRi Lentiviral sgRNA Libraries
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Human and Mouse Genome-Wide CRISPRa/CRISPRi libraries from $9,500; Dual-sgRNA libraries from $10,500; Custom libraries available.

cellecta.com
3shRNA Pooled Knockdown Libraries
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Individual modules (55K) from $8,500 each; Complete 165K pool from $10,500; DECIPHER mouse modules from $5,000; Custom libraries available.

cellecta.com
4Cas9/dCas9-Expressing Cell Lines
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Cas9-expressing lines from $6,000; dCas9-VPH/VPR/KRAB lines from $6,300; Jurkat dCas9-VPH from $8,400; Clonal variants from $8,400.

cellecta.com
5DriverMap AIR TCR/BCR Profiling Kits
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Mouse DNA kit from $1,450; Mouse RNA kit from $1,450; Human/Mouse scAIR kits from $4,850; RNA Spike-In controls from $1,050.

cellecta.com
6DriverMap EXP Targeted RNA-Seq Kits
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Human Genome-Wide EXP kit available; Mouse Targeted EXP kit available. First-ever kit for expression profiling from dried blood microsamples (30 uL).

cellecta.com
7Cloning Vectors and Control Constructs
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Standard sgRNA cloning vectors from $850; CRISPRa/CRISPRi vectors from $850; CRISPR/shRNA control constructs from $390; CRISPR-Test activity kits from $995.

cellecta.com
8NGS Prep Kits
ModelUnit PricingBilling cadencePay-as-you-go
Notes

NGS Prep Kits for libraries from $1,275; Supplementary primer sets from $675; Sequencing services available (quote-based).

cellecta.com
9Bioinformatics Analysis Services
ModelOtherBilling cadencePay-as-you-go
Notes

Functional Genetic Screening Analysis, AIR Profiling Analysis, and Targeted RNA-Seq Analysis services available. Price TBD / quote-based.

cellecta.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 10 records shown
1CloneTracker
Description

Cell barcoding libraries and kits for clonal tracking and lineage analysis

cellecta.com
+9 more records
Core offering1 text field

Cellecta develops, manufactures, and sells pooled lentiviral CRISPR sgRNA libraries, shRNA knockdown libraries, and associated cell lines, reagents, and assays used by researchers for functional genomics screening. It also provides full-service CRISPR/RNAi screening, single-cell Perturb-Seq screening, NGS sequencing, DriverMap AIR (TCR/BCR immune receptor) profiling, DriverMap EXP (targeted RNA-Seq expression) profiling, and bioinformatics analysis for drug target and biomarker discovery.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • HEAT sgRNA modifications improve Cas9 interactions for more robust knockout efficiency
+1 more record
Product overview1 text field

Cellecta is a functional genomics company offering a comprehensive platform of pooled lentiviral libraries and services for genetic screening. The portfolio centers on CRISPR and RNAi technologies including CRISPR Knockout, CRISPRa, and CRISPRi pooled sgRNA libraries, alongside shRNA knockdown libraries for gene silencing. Key product lines include CloneTracker XP barcode libraries for single-cell analysis, DriverMap AIR for T-cell and B-cell receptor profiling, and DriverMap EXP for targeted RNA-Seq expression analysis. The company provides end-to-end solutions combining pre-made and custom libraries (sgRNA, shRNA, barcode), Cas9/dCas9 cell lines, lentiviral packaging reagents, NGS analysis kits and services, and professional bioinformatics analysis. Services span CRISPR/RNAi screening, single-cell CRISPR screening, cell engineering, and sequencing services. The platform enables researchers to perform genome-wide or targeted genetic screens to identify drug targets and biomarkers.

Product and service23 records
1CRISPR Knockout Pooled Lentiviral sgRNA Libraries
CategoryCRISPR Knockout Libraries
Description

Pooled lentiviral sgRNA libraries used by researchers for unbiased phenotypic knockout screens in mammalian cell systems, enabling disruption of thousands of genes in a single experiment for functional genomics and drug target discovery.

2CRISPRa / CRISPRi Pooled Lentiviral sgRNA Libraries
CategoryCRISPRa/CRISPRi Libraries
Description

Pooled lentiviral sgRNA libraries for CRISPR activation (CRISPRa) and CRISPR interference (CRISPRi) screens, including unique dual-sgRNA constructs that enhance activation or repression effects.

3Custom sgRNA Libraries
CategoryCustom CRISPR Libraries
Description

Custom-designed CRISPR sgRNA pooled libraries targeting virtually any set of genes with customizable guide sequences and vector features for specialized screening applications.

4shRNA Knockdown Pooled Lentiviral Libraries
CategoryRNAi shRNA Libraries
Description

Pre-made and custom pooled lentiviral-based shRNA libraries used for genetic screening experiments to discover and functionally characterize therapeutic targets.

5Custom shRNA Libraries
CategoryCustom RNAi Libraries
Description

Custom pooled shRNA libraries targeting any set of genes with embedded shRNA barcodes for simplified sequencing readout in functional genomics screens.

6CloneTracker XP CRISPR Barcode Libraries
CategorySingle-Cell Perturb-Seq Libraries
Description

Pooled lentiviral libraries with barcoded sgRNA expression cassettes for Perturb-Seq, CROP-Seq, and CRISP-Seq single-cell analysis applications, enabling joint readout of guide RNA identity and transcriptomic response.

7Cas9 Cell Lines (Pre-made & Validated)
CategoryEngineered Cell Lines
Description

Off-the-shelf, functionally validated Cas9-expressing mammalian cell lines (including 293T, 786-O, 5637, A375, A549, A2058) for CRISPR knockout screens.

8dCas9-Expressing Cell Lines for CRISPRa/CRISPRi
CategoryEngineered Cell Lines
Description

Pre-made dCas9-expressing cell lines with various effector fusions (VPH, VPR, KRAB) for CRISPR activation and CRISPR inhibition experiments.

9CRISPR-Test Cas9 Activity Assays
CategoryActivity Assay Kits
Description

Flow cytometry-based assay kits to measure functional activity of Cas9 nuclease, dCas9-repressor, or dCas9-activator by quantifying GFP loss in engineered mammalian cells.

10NGS Prep Kits for sgRNA / shRNA Libraries
CategoryNGS Library Prep Kits
Description

Complete reagents and primers to generate sequencing-ready samples from genomic DNA for pooled lentiviral CRISPR, shRNA, and barcode libraries.

11DriverMap AIR TCR/BCR Repertoire Profiling
CategoryImmune Receptor Profiling Assays
Description

NGS-based assays for profiling T-cell receptor (TCR) and B-cell receptor (BCR) sequences from DNA or RNA, offered in bulk and single-cell formats for human and mouse samples.

12DriverMap EXP Targeted RNA-Seq Expression Profiling
CategoryTargeted RNA-Seq Expression Profiling
Description

Targeted RNA-Seq assays for gene expression profiling from limited samples, including human genome-wide and mouse targeted panels, with capability to profile as little as 30 uL of dried blood microsamples.

13DriverMap scAIR Profiling Kits
CategorySingle-Cell Immune Receptor Profiling
Description

Single-cell TCR/BCR profiling kits for human, mouse or hybrid samples providing high-resolution reliable TCR or BCR chain pairing data for adaptive immune receptor repertoire analysis.

14CRISPR/RNAi Screening Services
CategoryFull-Service Genetic Screening
Description

Full-scale genetic screening services using pooled lentiviral sgRNA and shRNA libraries to identify genes controlling specific phenotypes such as viability, growth, and pathway activation, for researchers who prefer outsourcing.

15Single-Cell CRISPR Screening Service
CategorySingle-Cell Screening Service
Description

Single-cell CRISPR screening service using Perturb-Seq, CRISPR-Seq, and CROP-Seq workflows to study the effects of CRISPR-based perturbations on mRNA expression.

16Custom Cas9 and dCas9-Variant Cell Line Service
CategoryCustom Cell Engineering Service
Description

Custom cell engineering service to generate stably expressing Cas9 or dCas9-activator/repressor cell lines validated with the CRISPR-Test assay for downstream screening applications.

17Sequencing Service for Samples from Genetic Screens
CategoryNGS Sequencing Service
Description

Full-service NGS processing including DNA extraction, amplification, Illumina sequencing, and enumeration of shRNA, sgRNA, or barcode counts from pooled lentiviral library screens.

18Bioinformatics Analysis Services
CategoryBioinformatics Analysis Services
Description

Professional computational biology services for functional genetic screening analysis, adaptive immune receptor profiling analysis, and targeted RNA-Seq analysis, including standard and custom reports.

19Tissue-2-Target Service
CategoryTissue-Based Target Discovery Service
Description

Service linking tissue samples to target identification for biomarker and drug discovery applications.

20HLA Typing Service
CategoryHLA Typing Service
Description

Service for human leukocyte antigen (HLA) typing using advanced sequencing methods to support immunology and transplantation research.

21LentiTrans Transduction Reagent
CategoryLentiviral Transduction Reagent
Description

Polybrene-based transduction reagent for enhancing lentiviral transduction efficiency in mammalian cell engineering workflows.

22LentiFuge Viral Concentration Reagent
CategoryLentiviral Concentration Reagent
Description

Reagent for concentrating lentiviral particles to achieve improved viral titer for transduction applications.

23LentiPrep Lentiviral Reagent Set
CategoryLentiviral Packaging Reagents
Description

Lentiviral reagent set with fluorescent control for monitoring packaging and transduction efficiency.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-05-01
Description

Partnership announced May 2025 to combine Neoteryx's Mitra VAMS (Volumetric Absorptive Microsampling) devices with Cellecta's DriverMap EXP profiling kit for at-home finger-prick blood collection with whole-genome expression analysis. This integration enables minimally invasive dried blood microsampling (as little as 30 uL) combined with Cellecta's targeted RNA-Seq expression profiling, expanding applications for decentralized healthcare and home-based diagnostics.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cellecta

Functional Genomics Research Tools and Servicescellecta.com

Cellecta is a private functional genomics company that develops and sells pooled lentiviral CRISPR and shRNA libraries, Cas9/dCas9 cell lines, immune-receptor profiling assays, and bioinformatics services to academic researchers, pharmaceutical companies, and CROs for drug-target and biomarker discovery.

What Cellecta does

Cellecta, Inc. is a private functional genomics tools and services company founded in 2006 and headquartered in Mountain View, California. The company develops and commercializes pooled lentiviral libraries and related reagents that enable CRISPR knockout, CRISPRa activation, CRISPRi interference, and shRNA knockdown screens in mammalian cells. Its catalog spans approximately 118 products across CRISPR and RNAi libraries, Cas9/dCas9-expressing cell lines, lentiviral packaging reagents, NGS prep kits, and CloneTracker cell-barcoding libraries for single-cell Perturb-Seq workflows, alongside specialized assays including DriverMap AIR (TCR/BCR repertoire profiling) and DriverMap EXP (targeted RNA-Seq expression profiling from samples as small as 30 uL of dried blood). Differentiated technologies include proprietary HEAT/HECG tracrRNA modifications for enhanced Cas9 interaction, commercially unique dual-sgRNA CRISPRa/CRISPRi constructs, and integrated barcoding libraries for clonal tracking.

Cellecta monetizes through a hybrid of one-time catalog product sales and fee-for-service engagements. Library products price from $8,500 to $10,500; Cas9/dCas9 cell lines from $6,000 to $8,400; DriverMap AIR kits from $1,450; and cloning vectors and controls from $390 to $850. Service revenue is generated from full-service CRISPR/RNAi screening, custom library construction, cell engineering, sequencing, and bioinformatics analysis, all priced on a quote basis. Distribution is primarily direct via a Shopify-based e-commerce platform, supplemented by phone/email sales and an international distributor network. A promotional pricing mechanism ("Buy a Library, Get 30% off a Support Product," expiring September 30, 2026) signals active commercial levers.

The company serves three primary customer segments: academic and government research institutions (universities, NIH-funded labs, research hospitals), pharmaceutical and biotechnology companies (target validation, CAR-T and immunotherapy development, drug-resistance studies), and CROs offering fee-for-service genomic screening. Marketing relies on scientific content, peer-reviewed citations, technical documentation, and conference participation (CCIC, SITC, AMP in 2026). Cellecta maintains two named leaders: founder and President Alex Chenchik, and Director of R&D Donato Tedesco. The company is funded in part through NIH grants and has not disclosed any external venture capital rounds or revenue figures. A May 2025 partnership with Neoteryx extends the DriverMap EXP platform into decentralized, at-home blood microsampling workflows.

Cellecta firmographics

Firmographics
Name
Cellecta
Legal name
Cellecta, Inc.
Website
https://cellecta.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
Cellecta is a private functional genomics company that develops and sells pooled lentiviral CRISPR and shRNA libraries, Cas9/dCas9 cell lines, immune-receptor profiling assays, and bioinformatics services to academic researchers, pharmaceutical companies, and CROs for drug-target and biomarker discovery.
Ownership category
akta.pro rank

Cellecta industry classification

Industry
Product category
Functional Genomics Research Tools and Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAAAIAG
CRISPR & Functional Genomics Screening Platforms (pooled/arrayed screens, perturb-seq)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)

Keywords

  • CRISPR pooled libraries
  • RNAi screening services
  • Functional genomics tools
  • Lentiviral sgRNA libraries
  • Immune receptor profiling

Where Cellecta is headquartered

Location

Headquarters

HQ city
Mountain View
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Cellecta business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Research Products (Libraries & Reagents): Sale of CRISPR sgRNA libraries, shRNA knockdown libraries, lentiviral constructs, Cas9 cell lines, cloning vectors, and related molecular biology reagents for functional genomics research.
  2. Screening Services: Full-service CRISPR/RNAi screening services including cell engineering, genetic screens, bioinformatics analysis, and sequencing services for customers who prefer outsourcing.
  3. Analysis Services: Bioinformatics data analysis services for genetic screens, AIR profiling assays, and targeted RNA-Seq including standard and custom reports.
  4. Custom Library Construction: Custom sgRNA and shRNA library design and production services targeting specific gene sets for research applications.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goCRISPR Knockout Pooled Lentiviral sgRNA Libraries
One time/ perpetual licensePay-as-you-goCRISPRa/CRISPRi Lentiviral sgRNA Libraries
One time/ perpetual licensePay-as-you-goshRNA Pooled Knockdown Libraries
Unit PricingPay-as-you-goCas9/dCas9-Expressing Cell Lines
Unit PricingPay-as-you-goDriverMap AIR TCR/BCR Profiling Kits
Unit PricingPay-as-you-goDriverMap EXP Targeted RNA-Seq Kits
Unit PricingPay-as-you-goCloning Vectors and Control Constructs
Unit PricingPay-as-you-goNGS Prep Kits
OtherPay-as-you-goBioinformatics Analysis Services

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Cellecta product offering

Product offering

Core offering

Cellecta develops, manufactures, and sells pooled lentiviral CRISPR sgRNA libraries, shRNA knockdown libraries, and associated cell lines, reagents, and assays used by researchers for functional genomics screening. It also provides full-service CRISPR/RNAi screening, single-cell Perturb-Seq screening, NGS sequencing, DriverMap AIR (TCR/BCR immune receptor) profiling, DriverMap EXP (targeted RNA-Seq expression) profiling, and bioinformatics analysis for drug target and biomarker discovery.

Product overview

Cellecta is a functional genomics company offering a comprehensive platform of pooled lentiviral libraries and services for genetic screening. The portfolio centers on CRISPR and RNAi technologies including CRISPR Knockout, CRISPRa, and CRISPRi pooled sgRNA libraries, alongside shRNA knockdown libraries for gene silencing. Key product lines include CloneTracker XP barcode libraries for single-cell analysis, DriverMap AIR for T-cell and B-cell receptor profiling, and DriverMap EXP for targeted RNA-Seq expression analysis. The company provides end-to-end solutions combining pre-made and custom libraries (sgRNA, shRNA, barcode), Cas9/dCas9 cell lines, lentiviral packaging reagents, NGS analysis kits and services, and professional bioinformatics analysis. Services span CRISPR/RNAi screening, single-cell CRISPR screening, cell engineering, and sequencing services. The platform enables researchers to perform genome-wide or targeted genetic screens to identify drug targets and biomarkers.

Differentiator

Problem solved

Functional benefit

Brands

  • CloneTracker: Cell barcoding libraries and kits for clonal tracking and lineage analysis
  • DriverMap AIR
  • DriverMap EXP
  • CRISPR-Test
  • CloneTracker XP
  • DECIPHER
  • LentiFuge
  • LentiTrans
  • LentiPrep
  • PromoterTest

Products and services

  • CRISPR Knockout Pooled Lentiviral sgRNA Libraries Pooled lentiviral sgRNA libraries used by researchers for unbiased phenotypic knockout screens in mammalian cell systems, enabling disruption of thousands of genes in a single experiment for functional genomics and drug target discovery.
  • CRISPRa / CRISPRi Pooled Lentiviral sgRNA Libraries Pooled lentiviral sgRNA libraries for CRISPR activation (CRISPRa) and CRISPR interference (CRISPRi) screens, including unique dual-sgRNA constructs that enhance activation or repression effects.
  • Custom sgRNA Libraries Custom-designed CRISPR sgRNA pooled libraries targeting virtually any set of genes with customizable guide sequences and vector features for specialized screening applications.
  • shRNA Knockdown Pooled Lentiviral Libraries Pre-made and custom pooled lentiviral-based shRNA libraries used for genetic screening experiments to discover and functionally characterize therapeutic targets.
  • Custom shRNA Libraries Custom pooled shRNA libraries targeting any set of genes with embedded shRNA barcodes for simplified sequencing readout in functional genomics screens.
  • CloneTracker XP CRISPR Barcode Libraries Pooled lentiviral libraries with barcoded sgRNA expression cassettes for Perturb-Seq, CROP-Seq, and CRISP-Seq single-cell analysis applications, enabling joint readout of guide RNA identity and transcriptomic response.
  • Cas9 Cell Lines (Pre-made & Validated) Off-the-shelf, functionally validated Cas9-expressing mammalian cell lines (including 293T, 786-O, 5637, A375, A549, A2058) for CRISPR knockout screens.
  • dCas9-Expressing Cell Lines for CRISPRa/CRISPRi Pre-made dCas9-expressing cell lines with various effector fusions (VPH, VPR, KRAB) for CRISPR activation and CRISPR inhibition experiments.
  • CRISPR-Test Cas9 Activity Assays Flow cytometry-based assay kits to measure functional activity of Cas9 nuclease, dCas9-repressor, or dCas9-activator by quantifying GFP loss in engineered mammalian cells.
  • NGS Prep Kits for sgRNA / shRNA Libraries Complete reagents and primers to generate sequencing-ready samples from genomic DNA for pooled lentiviral CRISPR, shRNA, and barcode libraries.
  • DriverMap AIR TCR/BCR Repertoire Profiling NGS-based assays for profiling T-cell receptor (TCR) and B-cell receptor (BCR) sequences from DNA or RNA, offered in bulk and single-cell formats for human and mouse samples.
  • DriverMap EXP Targeted RNA-Seq Expression Profiling Targeted RNA-Seq assays for gene expression profiling from limited samples, including human genome-wide and mouse targeted panels, with capability to profile as little as 30 uL of dried blood microsamples.
  • DriverMap scAIR Profiling Kits Single-cell TCR/BCR profiling kits for human, mouse or hybrid samples providing high-resolution reliable TCR or BCR chain pairing data for adaptive immune receptor repertoire analysis.
  • CRISPR/RNAi Screening Services Full-scale genetic screening services using pooled lentiviral sgRNA and shRNA libraries to identify genes controlling specific phenotypes such as viability, growth, and pathway activation, for researchers who prefer outsourcing.
  • Single-Cell CRISPR Screening Service Single-cell CRISPR screening service using Perturb-Seq, CRISPR-Seq, and CROP-Seq workflows to study the effects of CRISPR-based perturbations on mRNA expression.
  • Custom Cas9 and dCas9-Variant Cell Line Service Custom cell engineering service to generate stably expressing Cas9 or dCas9-activator/repressor cell lines validated with the CRISPR-Test assay for downstream screening applications.
  • Sequencing Service for Samples from Genetic Screens Full-service NGS processing including DNA extraction, amplification, Illumina sequencing, and enumeration of shRNA, sgRNA, or barcode counts from pooled lentiviral library screens.
  • Bioinformatics Analysis Services Professional computational biology services for functional genetic screening analysis, adaptive immune receptor profiling analysis, and targeted RNA-Seq analysis, including standard and custom reports.
  • Tissue-2-Target Service Service linking tissue samples to target identification for biomarker and drug discovery applications.
  • HLA Typing Service Service for human leukocyte antigen (HLA) typing using advanced sequencing methods to support immunology and transplantation research.
  • LentiTrans Transduction Reagent Polybrene-based transduction reagent for enhancing lentiviral transduction efficiency in mammalian cell engineering workflows.
  • LentiFuge Viral Concentration Reagent Reagent for concentrating lentiviral particles to achieve improved viral titer for transduction applications.
  • LentiPrep Lentiviral Reagent Set Lentiviral reagent set with fluorescent control for monitoring packaging and transduction efficiency.

Quantifiable outcome

  • HEAT sgRNA modifications improve Cas9 interactions for more robust knockout efficiency
  • +1 more outcomes

Companies that use Cellecta

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Cellecta technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Cellecta partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Neoteryx LLCcoreTechnology or Integration · 1 May 2025Partnership announced May 2025 to combine Neoteryx's Mitra VAMS (Volumetric Absorptive Microsampling) devices with Cellecta's DriverMap EXP profiling kit for at-home finger-prick blood collection with whole-genome expression analysis. This integration enables minimally invasive dried blood microsampling (as little as 30 uL) combined with Cellecta's targeted RNA-Seq expression profiling, expanding applications for decentralized healthcare and home-based diagnostics.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Cellecta competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Cellecta social profiles

Digital presence

Cellecta financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cellecta leadership team

Management profile

Number of profiles

Profiles2 records

Cellecta funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cellecta M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cellecta

What does Cellecta do?

Cellecta develops, manufactures, and sells pooled lentiviral CRISPR sgRNA libraries, shRNA knockdown libraries, and associated cell lines, reagents, and assays used by researchers for functional genomics screening. It also provides full-service CRISPR/RNAi screening, single-cell Perturb-Seq screening, NGS sequencing, DriverMap AIR (TCR/BCR immune receptor) profiling, DriverMap EXP (targeted RNA-Seq expression) profiling, and bioinformatics analysis for drug target and biomarker discovery.

Is Cellecta a public or private company?

Cellecta is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Cellecta founded?

Cellecta was founded in 2006. It employs 11 to 50 people.

Where is Cellecta based?

Cellecta is headquartered in Mountain View, United States, in the North America region.

How does Cellecta make money?

Four revenue lines are on record. Research Products (Libraries & Reagents) is the primary driver. The others are screening Services, analysis Services and custom Library Construction.

Does Cellecta have an API?

No public API is recorded for Cellecta.

What industry is Cellecta in?

Cellecta's product category is Functional Genomics Research Tools and Services. Its primary akta.pro industry code is HLAAAIAG, CRISPR & Functional Genomics Screening Platforms (pooled/arrayed screens, perturb-seq), with a secondary code of HLAGANAE, Transcriptomics & Gene Expression Profiling Services. Its NAICS code is 541714 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comIn-Depth Examination of Segments, Industry Trends, and Key Competitors in the Capillary Blood Collection Devices MarketThe global capillary blood collection devices market is projected to grow to $4.68 billion by 2030, representing an 11.1% compound annual growth rate, driven by home-based diagnostics, decentralized healthcare services, and increasing demand for minimally invasive blood collection methods. In May 2025, Neoteryx partnered with Cellecta, Inc. to combine Mitra VAMS devices with Cellecta's DriverMap EXP profiling kit for at-home finger-prick blood collection with whole-genome expression analysis. Additionally, Owen Mumford Ltd. (UK) launched the Unistik Heelstik product line in October 2023, designed specifically for neonatal and pediatric blood sampling across four developmental stages.PR NewswireCellecta, Inc. Launches Blood Microsampling Assay that Profiles 19,000 Human Protein-Coding Genes from One Drop of Dried BloodCellecta launched the DriverMap EXP Human Genome-Wide 19K Dried Blood Microsample Profiling kit, profiling 19,000 protein-coding genes from 30 microliters of dried whole blood. The assay uses Neoteryx VAMS microsamplers and Illumina sequencing, with a single-day workflow. It is available in 24- and 96-sample configurations.PR NewswireCellecta, Inc. Launches DriverMap™ Adaptive Immune Receptor (AIR) Human RNA Spike-In Controls to Ensure Consistent Quality and Optimal Performance of TCR and BCR Profiling AssaysCellecta, Inc. announced the launch of DriverMap™ AIR Human RNA Spike-In Controls, described as the first commercially available synthetic mRNA constructs that can serve as universal controls for adaptive immune receptor repertoire sequencing assays. The controls consist of 48 B-Cell Receptor and 39 T-Cell Receptor synthetic mRNA constructs designed to measure accuracy, sensitivity, and linear range while eliminating bias from PCR, NGS, and batch-to-batch experimental variation. The product aims to enable data harmonization and improve reproducibility of AIR-Seq, TCR-seq, and BCR-seq assays for immunology research.PR NewswireCellecta, Inc. Launches Genome-Wide CRISPR Chicken and Pig Knockout LibrariesCellecta, Inc. announced the release of new pooled, single-module, CRISPR genome-wide knockout libraries for chicken and pig, featuring 69,000 guides targeting 17,000 chicken genes and 89,000 guides targeting 22,000 pig genes. The libraries incorporate Cellecta's HEAT1 sgRNA structure designed to improve signal-to-noise ratios and knockout efficiency in pooled genetic screens. These tools are intended to enable researchers to identify genes responsible for advantageous traits such as pathogen resistance, improved breeding, and nutritional content in agricultural and dietary research applications.PR NewswireTHE CURELINE GROUP and CELLECTA, Inc Partner to Launch Tissue 2 Target™ ServicesThe Cureline Group and Cellecta, Inc. have launched a strategic partnership called Tissue 2 Target™ to combine human biospecimen management with molecular analysis capabilities for pre-clinical and translational research. The partnership aims to provide researchers with streamlined workflows for biomarker discovery and target validation, including sample collection, assay services, and data analysis pipelines. Both companies expect the collaboration to offer new opportunities for clients working on human disease biomarker R&D.PR NewswireCellecta, Inc. Launches DriverMap™ Adaptive Immune Receptor (AIR) TCR and BCR Kits for Comprehensive Immune Repertoire ProfilingCellecta, Inc. announced the launch of its DriverMap Adaptive Immune Receptor (AIR) TCR and BCR kits, a multiplex-PCR, NGS-based assay that enables profiling of up to all seven T-cell and B-cell receptor chains from a single sample without specialized equipment. The company claims the technology offers more comprehensive, sensitive, and quantifiable results compared to existing immune receptor profiling options on the market. Cellecta is also offering the DriverMap AIR Profiling assay as a service for researchers, with sample analysis and reporting provided through MiXCR software.PR NewswireCellecta Introduces GeoMx Digital Spatial Profiling Service to Provide Novel Insights into Tumor BiologyCellecta announced the launch of its RNA Spatial Profiling Service using NanoString's GeoMx Cancer Transcriptome Atlas, becoming one of the few designated GeoMx Premier Access Site Partners worldwide. The service enables researchers to submit fresh-frozen or FFPE tissue samples for gene expression profiling and spatial analysis of tumor microenvironments. NanoString's senior vice president welcomed Cellecta into their global service network, citing Cellecta's expertise in RNA expression profiling as a benefit to cancer researchers.PR NewswireCellecta, Inc. Launches DriverMap™ Predesigned RNA-Seq Panels and Analysis SoftwareCellecta, Inc. announced the launch of five DriverMap Predesigned RNA-Seq Panels on December 10, 2018, targeting gene expression analysis for disease, drug response, immune response, and related phenotypes. Each panel measures expression levels of curated essential genes ranging from approximately 1,285 to 4,304 genes, derived from publications and public databases including ENCODE, FANTOM, ImmGen, and DrugBank. The panels are designed for use with Illumina sequencing platforms and include alignment software for data analysis in Excel format.PR NewswireCellecta, Inc. Introduces CRISPRa and CRISPRi Genome-Wide sgRNA Libraries and Mouse Genome-Wide CRISPR Knockout Library to Expand Functional Genomic Screening PortfolioCellecta, Inc. introduced new CRISPRa and CRISPRi genome-wide screening libraries for human and mouse, along with a Mouse Genome-Wide CRISPR Knockout Library, expanding its functional genomic screening portfolio. The new libraries enable researchers to modulate gene expression without modifying genomic DNA, offering reversible effects compared to permanent knockout approaches, with coverage of approximately 19,000 human genes and 20,000 mouse genes. Cellecta, headquartered in Mountain View, California, positioned the launch as enabling researchers to accelerate therapeutic discovery and study gene function using state-of-the-art technology.